Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AgfiledCriticalBayer Ag
Publication of CU22988A3publicationCriticalpatent/CU22988A3/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Saccharide Compounds
(AREA)
Abstract
La presente invención se refiere a amidas de ácidos fenilciclohexanocarboxílicos de fórmula (I) que inhiben la captación de adenosina, a procedimientos para su preparación y a su uso en medicamentos, especialmente para el tratamiento de enfermedades cerebrales isquémicas. ESPACIO PARA FÓRMULA.The present invention relates to phenylcyclohexanecarboxylic acid amides of formula (I) that inhibit the uptake of adenosine, to methods for its preparation and its use in medicaments, especially for the treatment of ischemic brain diseases. SPACE FOR FORMULA.
CU20010271A1999-05-292001-11-19
AMIDAS OF PHENYCLYCHAHEXANOCARBOXYLIC ACIDS REPLACED WITH INHIBITING EFFECT OF ADENOSINE CAPTURE
CU22988A3
(en)
PHARMACEUTICAL COMPOSITION, PROCESS TO INHIBIT SELECTINUM-MEDIATED INTERCELLULAR ADHESION IN A PATIENT, PROCESS TO TREAT AN INFLAMMATORY DISEASE, PROCESS TO TEST A TEST COMPOUND AS THE ABILITY TO INHIBIT CELLULAR ADHESION MEDIATED BY SELECTINE AND PROCESSED A SELECTIN PROCESSES
compound, process for preparing same, pharmaceutical composition, method for treating inflammation or preventing apoptosis in an individual, and use of the compound
[6,7-Dihydro-5h-imidazole [1,2-alpha] imadazol-3-sulfonyl mino] propionamide derivatives, pharmaceutical composition, use thereof, and process for their preparation